About
About Avecho
Board & Leadership
TPM
®
Technology
Portfolio
Pipeline
Phase III Trial
Cannabinoids
Pharmaceutical
Animal Health
Manufacturing
Invest
Investor Centre
Media Centre
Contact
Hit enter to search or ESC to close
Phosphagenics Mylan Arbitration Hearing Concluded
November 9, 2017
Click here to read more
Post navigation
Previous Post
Phosphagenics Entitlement Offer Raises Over AUD3M
Next Post
Phosphagenics Provides Update on TPM Propofol Development Program
Related Posts
CEO Update – Teleconference
March 20, 2018
Phosphagenics Signs Non-Binding Term Sheet for Oxymorphone Patch in Japan
January 31, 2017
2016 July 29 CEO Quarterly Update
July 29, 2016